The US Food and Drug Administration (FDA) has given the green light to Neuralink, a company founded by Elon Musk, to conduct human trials in brain-computer interface (BCI) technology. This technology involves implanting a tiny chip in the brain that can read and interpret neural signals.
Founded in 2016, the company aims to treat brain diseases and eventually perform human enhancement and augmentation, where biological implants theoretically alter the body to improve physical and mental capabilities. It has been conducting trials in animals like monkeys and pigs since 2018.
Keep Reading This Article at MSN.com